Evolution of Alzheimer's Disease Cerebrospinal Fluid Biomarkers in Early Parkinson's Disease

OBJECTIVE: We analyzed the longitudinal profile of Alzheimer's disease (AD) cerebrospinal fluid (CSF) biomarkers in early Parkinson's disease (PD) compared with healthy controls (HCs) and tested baseline CSF biomarkers for prediction of clinical decline in PD. METHODS: Amyloid‐β 1 to 42 (A...

Descripción completa

Detalles Bibliográficos
Autores principales: Irwin, David J., Fedler, Janel, Coffey, Christopher S., Caspell‐Garcia, Chelsea, Kang, Ju Hee, Simuni, Tanya, Foroud, Tatiana, Toga, Arthur W., Tanner, Caroline M., Kieburtz, Karl, Chahine, Lana M., Reimer, Alyssa, Hutten, Samantha, Weintraub, Daniel, Mollenhauer, Brit, Galasko, Douglas R., Siderowf, Andrew, Marek, Kenneth, Trojanowski, John Q., Shaw, Leslie M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497251/
https://www.ncbi.nlm.nih.gov/pubmed/32542885
http://dx.doi.org/10.1002/ana.25811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7497251/
https://www.ncbi.nlm.nih.gov/pubmed/32542885
http://dx.doi.org/10.1002/ana.25811

Ejemplares similares